Treatment after failure: The problem of 'non-responders'

Gut

Volumn 45, Issue SUPPL. 1, 1999, Pages

  Huang, J Q ^a   Hunt, R H ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DOSE RESPONSE; DRUG CHOICE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; STRAIN DIFFERENCE; TREATMENT FAILURE;

DRUG RESISTANCE, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 0032995649     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. 1 McNulty CAM, Gearty JC, Crump B, et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. BMJ 1986;293:645-9.
2. 2 Huang JQ, Hunt RH. Review: eradication of Helicobacter pylori: problems and recommendations. J Gastroenterol Hepatol 1997;12:590-8.
3. 3 Hunt RH. Eradication of Helicobacter pylori infection. Am J Med 1996;100(suppl 5A):42-51S.
4. 4 Peura DA and the American Digestive Health Foundation. The report of the Digestive Health Initiative international update conference on Helicobacter pylori. Gastroenterology 1997;113:S4-8.
5. 5 Hunt RH, Thomson ABR. Canadian Helicobacter pylori consensus conference. Can J Gastroenterol 1998;12:31-41.
6. 6 European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41: 8-13.
7. 7 Lam SK, Talley NJ. Helicobacter pylori consensus: report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
8. 8 Glupczynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure 1998. London: Kluwer Academic Publishers, 1998:398-415.
9. 9 Graham D, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
10. 10 Huang J-Q, Chiba N, Wilkinson JM, et al. Which combination therapy can eradicate ≥90% Helicobacter pylori (H. pylori) infection? A meta-analysis of amoxicillin, metronidazole, tetracycline und clarithromycin containing regimens [abstract]. Gastroenterology 1997;112:A19.
11. 11 Pipkin GA, Williamson R, Wood JR. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998;12:823-37.
12. 12 Wermeille J, Dederding JP, Cunningham M, et al. Failure of Helicobacter pylori eradication in an ambulatory population: is poor compliance the main cause? Digestion 1998;59(suppl 3):437.
13. 13 Goh KL, Parasakthi N, Chuah SY, et al. Comparison of two 1-week low-dose omeprazole triple therapies optimal treatment for Helicobacter pylori infection? Aliment Pharmacol Ther 1997;11:1115-18.
14. 14 Adamek RJ, Suerbaum S, Pfaffenbach B, et al. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin - influence on treatment outcome. Am J Gastroenterol 1998;93:386-9.
15. 15 Bazzoli F, Zagari M, Pozzato P, et al. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther 1998;12:439-45.
16. 16 Buckley MJ, Xia HX, Hyde DM, et al. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci 1997;42:2111-15.
17. 17 Harris AW, Pryce DI, Gabe SM, et al. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10: 1005-8.
18. 18 Misiewicz JJ, Harris AW, Bardhan KD, et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997; 41:735-9.
19. 19 Peitz U, Nusch A, Tillenhurg B, et al. High cure rate of H. pylori (HP) infection by one-week therapy with omeprazole (OME), metronidazole (MET) and clarithromycin (CLA) despite a negative impact by MET resistance [abstract]. Gut 1996;39(suppl 2):A5.
20. 20 Moayyedi P, Ragunathan PL, Mapstone N, et al. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1998;33(suppl 10):62-5.
21. 21 Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996;24:37-41.
22. 22 Xia H, Keane CT, Beattie S, et al. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 1994;38:2357-61.
23. 23 Megraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998;43(suppl 1):S61-5.
24. 24 Xia HH, Kalantar J, Talley NJ. Metronidazole-and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol 1998;13:1044-9.
25. 25 Lind T, Mégraud F, Bardhan KD, et al. The MACH 2 study: antimicrobial resistance in Helicobacter pylori therapy - the impact of omeprazole. Gut 1997;41(suppl 1):A89.
26. 26 Bell GD, Bate CM, Axon AT, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther 1995,9:513-20.
27. 27 Veldhuyzen van Zanten S, Hunt RH, Cockeram A, et al. Adding once-daily omeprazole 20 mg to metronidazole/ amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. Am J Gastroenterol 1998;93:5-10.
28. 28 Lind T, Bardhan KD, Bayerdörffer E, et al. The MACH 2 study: optimal Helicobacter pylori therapy needs omeprazole and can be assessed by UBT [abstract]. Gastroenterology 1997;112:A200.
29. 29 Tompkins DS, Perkin J, Smith C. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 1997;2:185-7.
30. 30 Miyaji H, Azuma T, Ito S, et al. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther 1997;11;1131-6.
31. 31 Marais A, Monteiro L, Lamouliatte H, et al. Cag negative status of Helicobacter pylori is a risk factor for failure of PPI-based triple therapies in non-ulcer dyspepsia [abstract]. Gastroenterology 1998;114:A214.
32. 32 Huang JQ, Hunt RH. Are one-week anti-H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)? A meta-analysis [abstract]. Am J Gastroenterol 1998;93:119.
33. 33 Go MF, Graham DY. Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis. Helicobacter 1996;1:107-11.
34. 34 Catalano F, Catanzaro R, Bronga A, et al. Duodenal ulcer and functional dyspepsia: different susceptibility of Helicobacter pylori to eradicating therapy [abstract]. Gastroenterology 1997;112:A84.
35. 35 Luna P, del Castillo G, Farias R, et al. Efficacy and tolerability of a seven-day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori [abstract]. Gastroenterology 1997;112:A202.
36. 36 Moayyedi P, Langworthy H, Shanahan K, et al. Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter 1996;1:71-4.
37. 37 Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
38. 38 Huang JQ, Wilkinson JM, Hunt RH. Lansoprazole (L) given bid is better than once daily in combination with antibiotic(s) for eradicating H. pylori infection: a meta-analysis [abstract]. Am J Gastroenterol 1997;92:1616.
39. 39 Laine L, Estrada R, Trujillo M, et al. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:1029-33.
40. 40 Ricci C, Menegatti M, Landi F, et al. Failure of eradicating Helicobacter pylori (HP) treatment: which is the next step? Digestion 1998;59(suppl 3):427.
41. 41 Houben MHMG, van de Beek D, van 't Hoff BWM, et al. PPI-triple therapy failure in Helicobacter pylori (Hp) infection: re-treatment with PPI-triple therapy or quadruple therapy? Digestion 1998;59(suppl 3):413.
42. 42 Sheu BS, Wu JJ, Yang SB, et al. One-week proton pump inhibitor-based triple therapy is effective to eradicate the residual H. pylori after dual therapy. Digestion 1998; 59(suppl 3):430.
43. 43 Rinaldi V, Zullo A, Pugliano F, et al. The management of failed dual or triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1997;11:929-33.
44. 44 Gisbert JP, Boixeda D, Bermejo F, et al. Re-treatment after H. pylori eradication failure: which therapy is better? Digestion 1998;59(suppl 3):410.
45. 45 vd Wouden EJ, Thijs JC, van Zwet AA, et al. Metronidazole resistance does not influence the efficacy of triple therapy with ranitidine bismuth citrate (RBC), clarithromycin (CLA) and metronidazole (MET) for H. pylori (Hp) infection [abstract]. Gastroenterology 1998;114:A323.
46. 46 Graham DY, Hoffman J, Osato MS, et al. New therapy for metronidazole or clarithromycin resistant Helicobacter pylori: FOC or FOM [abstract]. Gastroenterology 1998;114: A138.
47. 47 Moshkowitz M, Konikoff FM, Peled Y, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015-19.